OUR CLINICAL TRIALS

DESTINY-Breast05

A phase 3, multicenter, randomized, open-label, active-controlled study of trastuzumab deruxtecan (T-DXd) versus trastuzumab emtansine Leer mas

DOLAF

DOLAF- An international multicenter phase II trial of Durvalumab (MEDI4736) plus OLAparib plus Fulvestrant in Leer mas

ECTO II (FM-B04-01)

European cooperative study of primary systemic therapy in women with operable breast cancer and T Leer mas

ELIPSE

ELacestrant In Preoperative SEtting, a window of opportunity study Leer mas

EXPERT

A randomised phase III trial of adjuvant radiation therapy versus observation following breast conserving surgery Leer mas

FAIRLANE

A phase II randomized, double-blind, study of ipatasertib (GDC-0068), an Akt inhibitor, in combination with Leer mas

HER2-PREDICT

Translational Study Of Tumor Samples From DS8201- A-U301 and DS8201-A-U302 Trials Leer mas

HER2CLIMB

Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Leer mas

HERA

A randomized, three-arm, multicenter comparison of 1 year and 2 years of Herceptin® versus no Leer mas